Unexpected and serious toxicity observed with combined idelalisib, lenalidomide and rituximab in relapsed/refractory B cell lymphomas: Alliance A051201 and A051202
- Citation:
- Blood vol 124 (21) Abstr 3091
- Meeting Instance:
- ASH 2014
- Year:
- 2014
- Type:
- Abstract
- Sub type:
- Poster Discussion
- Funding:
- NCTN
- Endpoint:
- Secondary
- Analysis:
- Meta-Analysis
- Data Sharing:
- No-Data-Sharing
- Status:
- Presented/Published
- Citation Status:
- pub
- Note:
- Methodological:
- No
- Biospecimen:
- No
- SDC:
- No
- Parents:
- None
- Children:
- 2584
- Pharmas:
- Grants:
- Corr. Author:
- Authors:
- Sonali M. Smith Brandelyn N. Pitcher Sin-Ho Jung Nancy L. Bartlett Nina Wagner-Johnston Steven I. Park Kristy L. Richards Amanda F. Cashen Bruce D. Cheson John P. Leonard
- Networks:
- Study
- Multiple Studies, or Legacy Studies in Alliance Study:
- Alliance-A051201, Alliance-A051202
- Phases:
- 1
- Keywords: